Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
The use of biphasic linear ramped pulsed field gel electrophoresis to quantify DNA damage based on fragment size distributionT S Lawrence, D P Normolle, M A Davis, et al.
Cancer Research|September 1, 1989
Dependence of etoposide-induced cytotoxicity and topoisomerase II-mediated DNA strand breakage on the intracellular ionic environmentT S Lawrence, C E Canman, J Maybaum, et al.
Molecular Pharmacology|March 1, 1991
Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cellsC E Dusenbury, M A Davis, T S Lawrence, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1997
A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancerJ M Robertson, W D Ensminger, S Walker, et al.
International Journal of Radiation Biology|September 1, 1996
Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progressionT S Lawrence, M A Davis, H Y Tang, et al.
Radiation Research|May 27, 2004
The role of Bcl-X(S) in radiation sensitivityM A Morgan, J N Poynter, J Maybaum, et al.
Radiation Oncology Investigations|January 1, 1997
Effect of p53 overexpression on radiation sensitivity of human colon cancer cellsR C Zellars, J D Naida, M A Davis, et al.
Cancer|February 1, 1994
Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridineD J Buchsbaum, M B Khazaeli, M A Davis, et al.
The Journal of Cell Biology|January 1, 1979
Hormonally induced cell shape changes in cultured rat ovarian granulosa cellsT S Lawrence, R D Ginzberg, N B Gilula, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cellsM D Axelson, M A Davis, S P Ethier, et al.
Pageof 17